Investing.com UK - Financial Markets Worldwide
Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday

Published 20/03/2023, 16:37
© Reuters. Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday
SCHW
-
IXIC
-
TGTB34
-
SCHW34
-

Benzinga -

  • HC Wainwright & Co. cut the price target for 89bio, Inc. (NASDAQ: ETNB) from $27 to $25. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. 89bio shares fell 5.2% to trade at $11.80 on Monday.
  • EF Hutton boosted the price target for Atlas Lithium Corporation (NASDAQ: ATLX) from $12 to $18. EF Hutton analyst Chip Moor maintained a Buy rating. Atlas Lithium shares gained 1.5% to trade at $13.85 on Monday.
  • Guggenheim raised the price target for Academy Sports and Outdoors, Inc. (NYSE: ASO) from $63 to $70. Guggenheim analyst John Heinbockel maintained a Buy rating. Academy Sports shares gained 1.6% to $64.29 on Monday.
  • BTIG boosted Verona Pharma plc (NASDAQ: VRNA) price target from $26 to $31. BTIG analyst Thomas Shrader maintained a Buy rating. Verona Pharma shares gained 2.4% to trade at $19.04 on Monday.
  • B. Riley Securities cut Marathon Digital Holdings, Inc. (NASDAQ: MARA) price target from $6 to $5. B. Riley Securities analyst Lucas Pipes maintained a Neutral rating. Marathon Digital shares fell 5.8% to $7.71 in pre-market trading.
  • Raymond James raised the price target for Extra Space Storage Inc. (NYSE: EXR) from $170 to $185. Raymond James analyst Jonathan Hughes maintained an Outperform rating on the stock. Extra Space Storage shares fell 0.1% to trade at $159.29 on Monday.
  • Rosenblatt boosted Stagwell Inc. (NASDAQ: STGW) price target from $10 to $12.. Rosenblatt analyst Barton Crockett maintained a Buy rating. Stagwell shares gained 6% to $6.89 on Monday.
  • Benchmark cut RCM Technologies, Inc. (NASDAQ: RCMT) price target from $30 to $28. Benchmark analyst Bill Sutherland maintained a Buy rating. RCM Technologies shares fell 3.7% to trade at $12.37 on Monday.
  • Cantor Fitzgerald raised MoonLake Immunotherapeutics (NASDAQ: MLTX) price target from $23 to $29. Cantor Fitzgerald analyst Prakhar Agrawal maintained an Overweight. MoonLake Immunotherapeutics shares fell 15.8% to trade at $19.48 on Monday.
  • Goldman Sachs raised Jabil Inc. (NYSE: JBL) price target from $80 to $90.. Goldman Sachs analyst Mark Delaney maintained a Buy rating. Jabil shares gained 1.9% to trade at $80.49 on Monday.
  • Credit Suisse increased The Charles Schwab Corporation (NYSE: SCHW) price target $67.5 to $68. Credit Suisse analyst Bill Katz maintained an Outperform rating. Charles Schwab shares gained 1.1% to trade at $57.07 on Monday.
Check This Out: Bitcoin Rises Above $28,000; Conflux Becomes Top Gainer

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.